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INTRODUCTION 
THORACOSCOPY OR MEDICAL PLEUROSCOPY: 
                        The technique of medical thoracoscopy (or pleuroscopy) 
involves passing an endoscope through the thoracic cage and allows direct 
visualization and biopsies from the pleura. It is both a diagnostic and 
therapeutic procedure.  
 
                       Pleural fluid analysis, blind pleural biopsy, transthoracic 
needle aspiration are not always able to achieve a diagnosis in all cases. It 
is in this context that medical pleuroscopy or thoracoscopy is useful since 
the pleurae can be visualized and adequate sampling can be done. 
 
HEMORRHAGIC OR BLOOD TINGED EFFUSIONS: 
                          More than 15% of transudative and more than 40% of all 
types of exudative pleural fluids are blood tinged which means they have 
pleural fluid RBC counts between 5,000 and 100,000/mm3. Hemorrhagic 
pleural effusions are considered to be secondary to malignancy unless 
otherwise proved. 
 
                           In this study all patients who had hemorrhagic pleural 
effusions and underwent a thoracoscopy between May 2011 and April 2012 
were analysed. The demographic, clinical, radiological, per operative 
findings and the final diagnosis were studied and the value of medical 
thoracoscopy in hemorrhagic effusions was assessed and reported. 
 
THE GOVERNMENT HOSPITAL OF THORACIC MEDICINE, 
TAMBARAM SANATORIUM, CHENNAI: 
                              The government hospital of thoracic medicine at 
Tambaram sanatorium is a tertiary care referral centre located in Chennai, 
Tamilnadu. It is an apex centre for the diagnosis and treatment of 
respiratory diseases including tuberculosis. It is attached to Stanley medical 
college, Chennai and is a postgraduate teaching centre. 
 
                                This hospital has around 776 beds. There are thirty one 
in-patient wards. The outpatient department receives around one thousand 
patients [main OPD and HIV OPD] daily. It is one of the biggest AIDS 
care centre in the country with around three hundred HIV patients visiting 
the separate HIV OP department daily. Another three hundred patients take 
in-patient treatment in eight exclusive HIV wards. 
 Govt. ho
Govt.  H
spital of t
ospital of 
 
horacic m
Thoracic 
edicine –
Medicine
entrance v
 - a ward
iew. 
 
                               
 This hospital provides good care and support to all types of chest diseases.  
                                Medical thoracoscopy is being done in government 
hospital of thoracic medicine for past 4 years. It is done in the fully 
functional operation theatre as per guidelines. 
                                Patients with pleural effusions are a common 
occurrence in this hospital. Diagnosing the underlying causes of pleural 
effusions is mandatory for appropriate treatment. Though tubercular 
effusions are the most common cause in our set up, other causes of 
effusions have to be ruled out before initiating anti-tubercular treatment. 
 
                                  Medical thoracoscopy is usually done in cases where 
prior diagnostic modalities have been unable to provide a definitive 
diagnosis. The usual investigations done for a case of pleural effusion are: 
• Chest x ray –PA view 
• Ultrasound chest 
• Diagnostic pleural tap 
        - Pleural fluid protein, glucose, Lactate Dehydrogenase levels, 
    Thoracoscopy Instruments. 
        - p H 
       - Pleural fluid cell count 
       - Pleural fluid cytology 
       - Pleural fluid Adenosine Deaminase levels 
 
• Blind pleural biopsy – Abram’s or Cope’s needle 
• Contrast enhanced computed tomography scan 
• Fibre optic bronchoscopy – if there is ipsilateral shift of 
mediastinum. 
• Medical thoracoscopy or pleuroscopy. 
 
                          Usually hemorrhagic or blood stained pleural effusions are 
considered malignant effusions unless otherwise proved not so. In 
accordance with this thought this study was designed to analyse the causes 
of hemorrhagic pleural effusions that were encountered during the routine 
diagnostic tapping.  
 
                            There are proven criteria for classifying exudative and 
transudative effusions. It was also planned as a part of the study design to 
formulate certain criteria for hemorrhagic effusions. Based on these criteria 
patients were accrued in to the study after the procedure of routine pleural 
tapping. 
                           Medical thoracoscopy involves the use of costly and 
technically advanced equipments and is widely known as a safe and 
effective means of obtaining specimens for histopathological examination 
by directly viewing both the pleural surfaces.  
                            
             This hospital is one of the very few centres in the state of 
Tamilnadu where medical thoracoscopy is available and  is being done 
routinely in the selected patient subsets. By doing this study it would be 
possible to ascertain whether thoracoscopy can be taken up as the very next 
step after diagnostic pleural tapping when the pleural fluid is hemorrhagic. 
                          
              Though this is possible in tertiary care centres, it will probably 
lead to an early diagnosis of the underlying cause of effusion. This is what 
prompted me to take up this particular issue  and  to try and come out with 
a breakup of the causes of hemorrhagic pleural effusions in our hospital.                 
         
              The following are the guidelines issued by the British thoracic 
society for medical thoracoscopy under local anaesthesia:- 
  
1. Place where the procedure can be performed - 
                                  Medical thoracoscopy can be performed in an 
operating theatre, endoscopy suite or clean treatment room, based on the 
availability of resources. 
 
The room must have the following: 
 
• Table: basic operating table with height adjustment.  
• Oxygen source and suction equipment.  
• pulse oximetry, 
• blood pressure recording  
• ECG monitoring.  
• resuscitation facilities.  
• instrument trolley. 
• Chest x ray lobby 
 
 
2. Personnel - 
 
• One trained respiratory physician               
• two other staff – one nurse and one trained worker  
 
3. Instruments - 
 
• rigid thoracoscope with a cold light source- zero degree 
straight viewing and fifty degree side viewing scopes with 7 
millimetre diameter 
 
• trocar and cannula seven millimetre diameter and 10 
centimetres in length- cone shaped tip is preferable to 
triangular tipped ones 
• another trocar and cannula with five millimetre diameter and 
10 cms length 
• biopsy forceps- five millimetre – either optical or direct 
vision type 
• swab holder 
• boutin or verres needle – for induction of pneumothorax. 
• Talc insufflators if pleurodesis is part of the planned 
procedure 
• Light source – preferably four hundred watts  
• Video apparatus 
• A camera to take photographs if needed 
• Sterile gloves, caps, 
• Sterile needles, syringes 
• Scalpel, needle holder, scissor,sutures,dressing materials 
• Intercostals drainage tube with underwater seal 
4. Pre-procedure assessment and care 
 
a. Care Pathway, Patient Information and Consent:  
• A standard protocol for assessment should be followed    
•  patient information leaflet should be given to the patient 
prior to obtaining consent 
• Fully informed consent should be obtained. 
b. Pre-operative Investigations:  
• complete blood count, 
•  platelet count,  
• coagulation profile, 
• serum electrolytes, 
• renal function tests 
• blood glucose.  
• ABG. 
•  chest X ray  
•  CT scan is required.  
•  Pre-procedure ultrasound  
c. Pre-operative Fasting:  
 
• Recommended duration of fasting is six-hours prior to procedure.  
 
d. Pre-operative measurements:  
• Temperature 
• Pulse rate 
• blood pressure 
• respiratory rate  
• oxygen saturations  
•  ECG  
• i.v cannula - in the hand on the same side as the planned 
procedure.  
 
 e. Pre-medication:  
• Ibuprofen 800 milligram orally 1 hr before surgery 
• Opiods 
 
f. Prophylactic antibiotics:  
• One dose of amoxicillin –clavulanic acid 1.2 mg I.V 
just before procedure 
 
g. Anticoagulants and heparin prophylaxis:  
• Oral anticoagulants should be stopped 1 week 
before surgery.  
• LMWH after starting procedure is advised.  
 
5. Positioning, Local Anaesthesia and Sedation 
                 a.   Positioning and monitoring: 
 
•  Lateral position with side of interest  
• Head kept on a soft rest with hands folded before face  
• A pillow is kept below chest 
• O2 saturation should be kept above 92% 
 
                b. Skin should be wiped with alcohol based sterilising solution 
                  
                c. Sedation used is midazolam 1 to 5 milligram slowly.   
Alternatively fentanyl 50 to 100 micrograms can be used 
                
                  d. Site of incision is 4th or 5th intercostal space .upto twenty ml 
of 1 % lidocaine can be used. 
                e. Incision size is 1 centimetre along the direction of ribs 
 
                f. A pneumothorax is induced if there is no adequate pleural 
space.  
 
6. Visualisation of the pleural space and pleural biopsy 
 
• Pleural biopsy is taken from parietal surface only. Fentanyl can be 
used just before taking a biopsy 
‘Lift and peel’ technique is used for biopsy 
• Minimum of four to five samples are to be taken 
• A second port is needed to take biopsies from difficult to reach sites. 
 
7. Interventional procedures 
 
• Pleurodesis can be done by talc insufflations 
• Adhesiolysis 
• Sympathectomy 
 
8. ICD – 28 to 32 F size is inserted 
  
 
9. Post-thoracoscopy care –  
                           
                               If lung does not expand in 24 hours ,gentle suction to 
tube can be applied. ICD tube is removed if drain is less than 150 ml per 
day. Chest X ray is taken 1 day after thoracoscopy. Opiods are 
recommended for post operative pain relief. 
 
10. Patients are generally advised to stay for 24 hours post procedure. 
 
11. Patients are then to be registered for regular follow up 
 
 
 
 
 
 
 
 
 
 
 
  
 
                                        LITERATURE REVIEW 
HISTORY: 
                                    Thoracoscopy was developed by Hans Christian 
Jacobaeus in the early 1900s .Thoracoscopy was used initially extensively 
for creating artificial pneumothorax in tuberculosis cases.  Later 
thoracoscopy was used primarily to assist in diagnosing pleural effusions 
and for pleurodesis talc or silver nitrate. 
 
                                     There have been many advances in endoscopic 
technology leading to great developments in thoracoscopy now. The 
development of the charged coupling device [CCD] and a silicon chip that 
is light sensitive actually led to sufficient miniaturization of a video 
camera. 
                                     When attached to a fiber-optic telescope, the video 
camera produces a well-defined and magnified image on a video monitor 
that allows the operating surgeon to view the area of interest with precision 
and to take the help of an assistant. Previously, the surgeon had to hold the 
thoracoscope; into which only he could look while working. This did not 
allow for the aid of an assistant and therefore, limited the complexity of the 
procedures done. 
 
PROCEDURE: 
                                     There are two techniques by which medical 
thoracoscopy can be performed. They are- single puncture and double 
puncture technique. Both techniques use a xenon light source. For the 
single puncture technique, a rigid thoracoscope with a 9-mm working 
channel is used.  
 
                                    Various instruments such as the biopsy forceps, 
needle biopsy, and suction catheter are used through the working channel, 
which can also accommodate electrocautery. In double puncture technique, 
a 7-mm rigid thoracoscope is used with a second smaller 5-mm trocar that 
is used for intervention procedures. 
 
                                  This procedure can be done either under direct visual 
control through the endoscopic optic or indirectly by video transmission. 
Other procedures like cauterization of adhesions and blebs, electro 
coagulation or laser coagulation can also be carried out. 
                                  Medical thoracoscopy is usually performed under 
local anesthesia with premedication. It is usually performed with the patient 
in the lateral decubitus position with the affected side facing upwards. 
 
                                   With the help of ultrasound and CT chest the site for 
the introduction of the thoracoscope is decided carefully avoiding major 
vessels. The thoracoscope should not be inserted too low because the 
diaphragm or spleen may be injured .The usual site for inserting the 
thoracoscope is the sixth or seventh intercostal space between the mid- and 
anterior-axillary lines. 
 
                                     Before the thoracoscope is introduced, if there is no 
adequate separation between the lung and chest wall; ideally a 
pneumothorax of several hundred ml of air is should be induced. Only then 
Examination of the pleural space is possible. After introduction of trocar all 
the pleural fluid should be removed .After that the entire pleural cavity is 
inspected. Biopsies are taken from suspicious areas, usually from the 
parietal pleural. After thoracoscopy, an intercostal drainage tube is 
introduced. 
                                         Ernst et al have developed a semi rigid 
pleuroscope in the evaluation of the pleural space. This pleuroscope 
operates much like a bronchoscope and is easier to use. 
 
INDICATIONS OF MEDICAL THORACOSCOPY: 
• Undiagnosed Pleural Effusion 
• Malignant Pleural Effusion 
• Para pneumonic Pleural Effusion 
• Postpneumonectomy empyema 
• Pneumothorax 
• Hemothorax 
• Chylothorax 
• Hepatic Hydrothorax 
• Staging of lung cancer 
• Pleurodesis 
• Site-directed biopsy of parietal pleura 
• Staging for mesothelioma 
 
                                     In a study by Harris et al, 182 patients were 
studied. These patients underwent thoracoscopy. They were studied for a 
five year period. He described a diagnostic sensitivity of ninety five percent 
for malignancy. Malignancy was proven by pleuroscopy in sixty six 
percent of patients who earlier had a closed pleural biopsy which was not 
diagnostic and in sixty nine percent of patients who had two reports of non 
diagnostic pleural cytology.  
 
                          In another study by Page et al, in one hundred and twenty 
one patients with undiagnosed pleural effusion nearly the same sensitivity 
was obtained. 
 
                          In an article published in the Journal of Medical 
Association of Thailand  in 2009 March,92 ., Supplement 2:S,19-23 titled 
“Outcome of medical thoracoscopy” done by Tscheikunaj, Silairatna and 
colleague of the Division of Respiratory Disease and Tuberculosis, 
Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol 
University, Bangkok, Thailand the following findings were reported.  
Between 1998 and 2007, one hundred and forty two procedures of medical 
thoracoscopy were performed.  
 
                          Of these 86 procedures were done in cases where the final 
diagnosis was not yet established. The yield was reported as 95.2%. The 
malignancy was diagnosed by thoracoscopy in 45.35% of cases. In cases 
where talc pleurodesis was done [22 patients] , three patients experienced 
failure of pleurodesis due to trapped lung. After a follow up of one twenty 
four days, seventeen patients had no recurrence. 
 
                          In fifteen patients who had loculated pleural effusion 
medical thoracoscopy was done but were successful in only 6 cases. For 
pneumothorax five were successes out of six procedures after a mean 
follow up of one hundred sixty seven days. In 12 cases of empyema, 
average hospital admission was 9.1 days post procedure. There were no 
serious adverse effects due to the procedure. 
 
                          In another article titled “medical thoracoscopy for 
undiagnosed pleural effusions, experience from a tertiary care hospital 
in North India” by Mootha VK,Jindal SK and colleagues from department 
of pulmonary medicine, Postgraduate Institute of Medical Education and 
Research, Chandigarh, India and published in Indian journal of chest 
diseases and allied sciences, 2011 January to March ,the following 
observations were made. 
                                       It was a retrospective analysis of medical 
pleuroscopies that were done from January 2007 to December 2008. The 
effusions were labelled as undiagnosed effusions if they had adenosine 
deaminase levels less than seventy IU/L and pleural fluid cytology for 
malignancy was not positive on three consecutive occasions. 
                                     The yield of thoracoscopy directed pleural biopsy 
for obtaining a diagnosis in such cases were evaluated. Complications of 
the procedure were also studied. The diagnostic yield of thoracoscopy 
directed pleural biopsy was around seventy four percent in patients 
classified as undiagnosed pleural effusions.  
 
                                   Malignancy was diagnosed in around forty eight 
percent of patients. There was one case of mesothelioma and other cases 
were secondary metastases to pleura. Lung and breast cancer were the most 
common sites of primary.  
 
                                  Tuberculosis was diagnosed in nearly twenty three 
percent of cases. They reported a low complication rate after procedure. 
Two cases of empyema were reported .They concluded that medical 
pleuroscopy is a safe procedure .it has good diagnostic yield in cases of 
undiagnosed effusions. 
 
                                     In another article titled “Predictors of Pleural 
Malignancy undergoing Thoracoscopy’ by Jaume Ferrer, MD; Juan 
Roldán, MD and colleagues published in CHEST 2005, they have reported 
sensitivity of ninety four percent and  specificity of hundred percent in the 
diagnosis of pleural malignancy. This was a prospective study of 93 
patients. Data were obtained before thoracoscopy by thorough clinical 
history, patient interview, and physical examination.  
 
                                     Chest X rays and CT scans were analysed by two 
independent persons. After thoracoscopic procedure, all patients who did 
not have a diagnosis were registered for long-term follow-up. The 
researchers suggest that factors associated with malignancy of pleura were- 
include a more than one month of symptoms, no fever, and blood stained 
pleural fluid and computed tomography of chest findings suggestive of 
malignancy. 
 
                                       They further went to state that these four criteria if 
applied had offered adequate classification in ninety five percent of 
patients. Among twenty-eight patients who were positive for all four 
criteria, each one had malignancy. Another 21 patients had maximum one 
criterion and it turned out that none had malignancy. 
 
                                     In an article published in Respirology Journal by 
Wilsher Ml and Veale AG from Green Lane Hospital in New Zealand 
titled “Medical Thoracoscopy in the Diagnosis of Unexplained Pleural 
Effusion” the authors conclude that thoracoscopic pleural biopsy has a very 
high sensitivity for the diagnosis of benign and malignant diseases and 
vastly increased the diagnostic yield for pleural effusion.  
 
                                   Theirs was a retrospective study. They reviewed the 
records of all patients who underwent medical thoracoscopy between 1990 
and 1996 .The study population was fifty eight. They had a minimum of 
two earlier diagnostic procedures including a blind pleural biopsy and 
pleural fluid cytology.  
 
                                    Among the patients 19 had mesothelioma, nine had 
pleural metastases and three had tuberculous pleuritis, six patients had 
asbestos related pleural fibrosis and three of the patients had post-
cardiotomy syndrome, one patient was diagnosed as chylous effusion, one 
was due to traumatic and two others had benign pleural effusions.  
 
                                    In seven cases the pleural space was not able to be 
adequately assessed, but none of these patients had ct chest or ultrasound of 
the pleural space before the procedure. There were five cases of false 
negativity for malignancy, but no false positivity.  
 
                                   The sensitivity to diagnose pleural malignancy by 
thoracoscopic directed biopsy was eighty five percent and specificity was 
one hundred percent. No life threatening complications were reported, but 
four patients had seeding of thoracoscopy port site by primary tumour. 
 
                                     The authors concluded that medical pleuroscopy 
was a safe procedure with a good diagnostic yield. Pre-operative ultrasound 
or CT chest enables good access to the pleural space and lead to better 
diagnostic yield. 
GENERAL CONSIDERATIONS: 
                                     Malignant effusions are considered as a sign of 
systemic disease rather than a localised one. The ideal treatment is that one 
which targets the malignancy systemically. But effective systemic 
treatment is frequently not feasible especially if the malignancy is 
refractory to systemic treatment. This is also the case in patients who have 
been already heavily treated. 
 
                                       In such circumstances locoregional treatment is 
needed for palliation of the symptoms. So in clinical practice the general 
considerations recommended are as follows: 
 
• ADEQUATE DRAINAGE: 
                                        Many of the malignant effusions recur within one 
to three days after a simple pleural aspiration. Another ninety seven percent 
of cases experience a recurrence within a month. Closed tube drainage with 
an intercostal tube allows effective drainage of the pleural effusion. 
 
                          It also allows the pleurae to oppose each other and hence 
may result in auto-pleurodesis. This will result in improvement in the 
general condition of the patient and preventing the recurrence of effusion. 
This can lead to a symptom free interval of a few weeks to months. But the 
primary disease remains to be treated. 
 
• AGENTS FOR INTRAPLEURAL INSTILLATION: 
                          The following agents can be used for intra pleural 
administration to create a pleurodesis: 
- Talc 
- Doxycycline 
- Bleomycin 
- Povidone iodine 
- Interferon alpha 
                          The most commonly used agents are sterile talc, 
tetracycline and bleomycin.  
                           The basic evaluation of all ctypes of lung cancers begins 
first by classification and staging of the disease 
The staging and the WHO classification are enumerated as follows: 
NCCN STAGING -2012- Lung Cancer  
 
T-  PRIMARY TUMOUR 
Tx - primary tumor not possible to see by radiology or FOB but 
bronchial wash or brush is positive for tumor. 
T0 – no evidence of primary malignancy 
Tis – carcinoma in situ 
T1 – tumor is less than 3 centimetres in the greatest dimension 
surrounded by lung or visceral pleura, with no bronchoscopic evidence 
of invasion before the lobe bronchus that is not main bronchus 
T1a - tumor less than or equal to 2 cm in the greatest dimension 
T1b  -  tumor more than 2 cms but less than 3 cms     
 
T2  - tumor size between 3 cms to 7 cms or  
           Tumor with the following features- any one  
            Involvement of the main bronchus  
            Or greater than or equal to 2 cms distal to the carina  
            Invasion of the visceral pleural surface 
            Or associated with atelectasis or obstructive pneumonitis till the                      
            hilar region but not involving the entire lung 
T2a - tumor greater than 3cms but less than or equal to 5 cms  
T2b – greater than 5 cms but less than or equal to 7 cms 
 
T3 – tumor greater than 7 cms or with direct invasion of anyone of 
following structure- chest wall includes superior sulcus tumors, 
diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium or a 
tumor in the main bronchus less than 2 cms from the carina but without 
involving the carina  or with atelectasis or obstructive pneumonitis of 
whole lung or separate tumor nodule o nodules in the same lobe 
 
T4 – tumor of any size with invasion of any following structures- 
mediastinum, heart , great vessels , trachea, recurrent laryngeal nerve, 
esophagus, vertebral body , carina, separate tumor nodule or nodules in 
a different ipsilateral lobe 
 
  
N   REGIONAL LYMPH NODES  
Nx - not able to be assessed 
 N0 – no regional lymph node metastases 
 N1 - metastases in ipsilateral peribronchial with or without  
same side hilar lymph nodes and intrapulmonary nodes including direct 
extension 
 N2 – metastases in same side mediastinal with or without subcarinal 
lymph nodes 
 N3 - metastases in opposite side mediastinal or hilar or same side scalene 
or supraclavicular lymph nodes 
 
M - DISTANT METASTASES: 
Mx – not able to be assessed 
M0 – no distant metastasis 
M1 - distant metastases 
 M1a – separate tumor nodules in opposite side lobe, tumor with nodules 
on the pleura or malignant pleural or pericardial effusion. 
M1b – distant metastases. 
TNM STAGE GROUPING 
T/M N0 N1 N2 N3 
T1a 1a 2a 3a 3b 
T1b 1a 2a 3a 3b 
T2a 1b 2a 3a 3b 
T2b 2a 2b 3a 3b 
T3 2b 3a 3a 3b 
T4 3a 3a 3b 3b 
M1a 4 4 4 4 
M1b 4 4 4 4 
 
WHO CLASSIFICATION OF MALIGNANT EPITHELIAL NON 
SMALL CELL LUNG TUMORS 
MAJOR SUBTYPE VARIANTS 
Squamous cell ca. Papillary 
 Clear cell 
 Small cell 
 Basaloid 
Adenocarcinoma Mixed 
 Acinar 
 Papillary 
 Bronchioloalveolar 
 Mucinous solid type 
Adenosquamous  
Large cell ca. Large cell neuroendocrine 
 Basaloid 
 Lymphoepitheliomas 
 Clear cell 
 Large cell rhabdoid 
Major subtype Variants 
Sarcomatoid ca. Pleomorphic 
 Spindle cell 
 Giant cell 
 Carcinosarcoma 
 Blastoma 
carcinoid Typical 
 Atypical 
Salivary gland Adenoid cystic 
 Mucoepidermoid 
 Epithelial myo epithelial 
  
 
SMALL CELL LUNG CANCER- STAGING 
Small cell carcinoma Limited 
 Extensive 
 
 
 
 
     OVERVIEW OF THE MANAGEMENT OF LUNG CANCER: 
                        Limited stage disease- disease confined to ipsilateral 
hemithorax which can be safely covered within a tolerable radiation 
portal. 
 
                        Extensive stage disease- disease beyond the ipsilateral 
hemithorax which may include malignant pleural or pericardial effusion 
or hematogenous metastases . 
 
                         According to Light`s text book, lung cancer causes a 
majority of   malignant pleural effusions.  Sometimes the pleural 
effusion is the first or initial presentation of the malignancy. During the 
disease progression nearly half of the patients develop effusions both 
unilateral and bilateral. 
 
                        One of the predictors for pleural effusions in cases of 
lung malignancy is the presence of anti- p 53 antibodies. In a case series 
quoted in light`s book nine out of ten patients that comes to around 90 
percent who had anti p53 antibodies had pleural effusions. In the same 
study forty two patients out of one hundred and fifteen patients that 
comes to around thirty six percent who were negative for the antibody 
did not have effusions. The reason for this occurrence or whether it has 
an etiopathological correlation is yet to be studied or scientifically 
proven.   
 
                              One another finding that has been suggested earlier is 
that even with extensive visceral pleural involvement pleural effusions 
do not occur. In a study paper from light`s one thousand seventy four 
patients who had surgery that is lung resection for curative purpose only 
about twenty seven percent had visceral pleural involvement. But these 
patients had a poor five year survival rate. This rate was around fifty 
percent. Another finding in this study was that the pleural fluid studies 
revealed higher positivity in case with visceral pleural involvement. 
 
                              When patients are treated with lung resection with 
curative intent for adenocarcinoma they may develop a pleural effusion. 
This is particularly positive if there is prior involvement of lymph node 
or the pleura itself by the tumour per se. These effusions had occurred 
after a mean time of eight months. 
                             The distressing fact about malignant pleural effusions 
is that these cases generally represent incurable disease thereby 
heralding a poorer prognosis. 
 
                              The management of malignant pleural effusions 
include the following steps- 
1.thoracentesis- for relief of dyspnea 
2. tube thoracostomy 
     3. pleurodesis 
     4. identification of the primary tumor 
     5. fibroptic bronchoscopy – if there is ipsilateral mediastinal shift 
      6.chemotherapy- systemic chemotherapy is used, intrapleural 
chemotherapy is not of proven benefit.  
      7. radiotherapy – in cases of lymphoma or small cell carcinoma. 
       8.pleurectomy - parietal pleurectomy in selected cases.   
 
                                Malignant pleural effusion is staged as M1a disease in 
the recent American joint committee for cancer staging manual seventh 
edition of 2010. 
                                    Sixty percent of small cell lung cancer and forty 
percent of lung cancer present with disseminated disease at diagnosis. 
 
                                    Around fifteen percent of lung cancer patients have 
pleural involvement at initial presentation and fifty percent of patients 
develop pleural effusions during the course of the disease. 
                                        Management of non small cell lung cancer is 
different from that of small cell cancer. Added to this management of such 
patients with effusions is still more difficult. The treatment of lung 
malignancies is given below:- 
 
MANAGEMENT OF NON SMALL CELL LUNG CANCER: 
            For stage 1, stage 2 and selected stage 3 patients surgery is standard 
of care. 
                 Neo adjuvant or adjuvant treatment is mostly required as 
complement to surgery in stage 2 stage 3 patients. Such management is 
possible in only twenty percent of lung cancer patients. 
 
       For stage 3 patients, concurrent chemotherapy with radiation is 
recommended. The chemotherapeutic agents used are  
- Cisplatin with etoposide 
- Cisplatin with vinorelbine 
- Cisplatin with vinblastine 
- Cisplatin with paclitaxel 
- Cisplatin with gemcitabine 
- Cisplatin with pemetrexed 
-  
                 All regimens are based on the primary drug namely 
cisplatin. So these regimens are called `cisplatin doublets` 
 
The doses used are  
 Cisplatin – 50 mg per m2 
Etoposide -100 mg per m2 
Vinorelbine- 25-30 mg per m2 
Vinblastine- 4 mg per m2 
Gemcitabine -1250 mg per m2 
Pemetrexed- 500 mg per m2 
 
 If patients are not able to tolerate cisplatin then alternative 
regimen of paclitaxel with carboplatin can be used. 
 
For patients in stage 4 disease the treatment options are 
- palliative chemotherapy 
- palliative radiotherapy 
- best supportive care 
 Palliative radiotherapy may be indicated in the following 
occasions- 
- major airway obstruction 
- severe hemoptysis 
- superior vena caval obstruction 
- pain due to skeletal secondaries in the weight bearing 
bones and spine 
- symptomatic brain secondaries    
With all the above management the five year survival rate 
for stage 1 disease is sixty five percent, stage 2 is forty 
one percent, stage 3 is only nine percent. The expected 
survival of stage 4 patients is less than a year           
 
  MANAGEMENT OF SMALL CELL CANCER: 
                                In less than five percent of patients with this disease 
early diagnosis in stage one is possible. Mostly the disease is diagnosed in 
late stages. T 1 and T2 node negative disease alone benefit from surgery. 
Otherwise all the patients are treated with chemotherapy and radiation. 
Small cell ca is highly responsive to both chemotherapy and radiotherapy. 
 
                                   Radiotherapy for lung cancer is best delivered by 
conformal techniques like three dimensional conformal 
radiotherapy,intensity modulated type,image guided variety since lung is 
mostly mobile during respiration. 
 
                                     The usual dose is forty five to sixty Gray in 1.8 to 2 
gray per fraction. Solitary lesions in periphery of lung can be treated with 
stereotactic radiosurgery or stereotactic body radiotherapy. Radiation is 
administered with proper immobilization methods and treatment planning 
system.              
MANAGEMENT OF TUBERCULOUS EFFUSIONS: 
                  Pleural fluid analysis in tuberculous pleural effusions usually 
reveal the following features : - 
Cell count analysis 
o exudates mostly , occasionally serous 
o blood stained in ten percent of cases 
o more than fifty percent of effusions are lymphocytic 
o mesothelial cells are usually less than five percent 
o eosinophils are less than fifty percent. If it is more 
than fifty percent then possibility of traumatic 
effusion should be considered 
Smear for tubercle bacillus 
o the smear for acid fast bacilli in pleural fluid is 
positive in less than ten percent of cases 
Culture for AFB 
o culture for tubercle bacillus is better sensitive. 
o The pleural fluid for culture should be collected in a 
heparinised container. 
o Bactec culture is advisable 
Closed biopsy- 
                          Cope`s or abram`s pleural biopsy needle yields granulomas 
in nearly fifty percent cases 
o Culture positivity in closed biopsy of pleura is around 
thirt to eighty percent. 
Adenosine deaminase levels -  
o Adenosine deaminase levels – more than seventy IU/L  is 
suggestive of tuberculous pleuritis 
o Adenosine deaminase levels type 2 is predominant in 
pleural fluid. 
o A ratio of type 1 to type 2 of less than 0.45 is more 
suggestive for tuberculosis. 
Interferon levels - 
o Pleural fluid interferon gamma levels are raised in these 
effusions 
o Other tests used are  
- Kaolin agglutination test for mycobacterial 
antibodies 
- Increase pleural fluid lysozyme. 
 
 Gold standard test 
 Thoracoscopy is the gold standard for diagnosis of tuberculous 
pleuritis . 
 The pleurae are covered by grayish white granulomas. 
 Polymerase chain reaction is also another useful test and is positive 
in thirty to sixty percent of culture negative pleural effusions 
 
TREATMENT OF TB EFFUSIONS – 
• Short course chemotherapy 
• Steroids are added after initiation of anti TB treatment 
• Dose of steroids is 0.5 to 0.75 mg/kg 
 
COMPLICATIONS –  
• Pleural thickening  
• Pleural fibrosis 
• Pleural calcification 
• Fibrothorax 
 
                    In human immunodeficiency virus infected patients 
pleural fluid tuberculosis bacteria yield is more . 
                     When the CD 4 count is less than two hundred there is 
more chance of AFB positivity in effusions. 
                      
                      In some cases non tuberculous mycobacteria can 
cause pleural effusions. Examples for such bacteria are 
• Mycobacterium avium intracellulare 
• Mycobacterium kansasii. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AIM OF THE STUDY: 
                          
                          To study the value of thoracoscopic biopsy performed 
in cases of hemorrhagic pleural effusions, done at a tertiary care hospital 
in Tamilnadu , South India . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
 
STUDY DESIGN:  Descriptive, prospective, observational study  
 
STUDY POPULATION: 
                             All patients who satisfied the inclusion criteria were 
included in the study. The total number of patients was 82. [Male-57, 
female-25] 
 
STUDY PERIOD:  May 2011 to April 2012 
 
INCLUSION CRITERIA: 
        1. Patients with clinically and radiologically confirmed pleural 
effusion 
        2. Patients with hemorrhagic pleural effusion defined by three criteria- 
                 [a] pleural fluid RBC < 2,00,000 per mm3, 
                 [b] Pleural fluid hematocrit < 50% of peripheral blood 
                 [c] Uniformly blood stained fluid in the tube while tapping of the 
effusion. 
 
EXCLUSION CRITERIA: 
     1. Patients with straw colored fluid during tapping 
     2. Pleural fluid RBC> 2, 00,000 per mm3 of blood 
     3. Pleural fluid hematocrit > 50 % - Hemothorax 
     4. Patients with only initially blood stained fluid in the tube 
     5. Patients not willing for the procedure 
     6. Bleeding diathesis 
 
INVESTIGATIONS: 
                            Apart from a detailed history & clinical examination, the 
following investigations were done- 
• complete haemogram 
• Bleeding time/Clotting time 
• sputum for AFB 
• mantoux, HIV-ELISA ,HBsAg, 
• Chest X Ray, CT scan Chest with contrast. 
• Pleural Fluid- AFB ,cell Count, sugar , protein, pH, hematocrit 
• Pleural Fluid- Cytology for malignant cells 
• Pleural Fluid RBC Count 
• Thoracoscopic Biopsy 
 
PROCEDURE: 
                            First an informed consent was obtained from the patient 
and his/her attenders. Only then was the patient subjected to the procedure. 
 
                            The patient was positioned with the diseased side up with 
a towel roll below the opposite axilla to expose the ribs more. The patient 
was monitored with a pulse oximeter probe throughout the procedure. The 
patient remained conscious throughout the procedure. After obtaining I.V 
access and ensuring availability of supplemental oxygen, the patient was 
draped and incisions made on the chest wall.  
 
                            Based on the procedure planned one or two incisions were 
made. Inspecting visceral and parietal pleura, pleural biopsy, release of 
adhesions, pleural abrasion, evacuation of fluid, searching for air leak sites 
were the procedures done after gaining visual access to the pleura with the 
thoracoscope. After the procedure an intercostal drainage [ICD] tube was 
put in place.  
 
                             The procedure was done in compliance with British 
Thoracic Society guidelines. The samples of pleural fluid were collected in 
heparinised test tubes and were subjected to the required investigations. 
 
                              In some patients, after the thoracoscopic biopsy, 
pleurodesis was done on table. The material used for pleurodesis was 
Povidone-iodine .In a few patients’ adhesiolysis was done during the 
thoracoscopic procedure to enable adequate lung expansion. The 
intercostals drainage tube was kept in place till the fluid drain per day fell 
to less than 100 ml/day after which it was removed. 
 
POSTOPERATIVE CARE: 
                              After the procedure, the patient was shifted to the 
intensive respiratory care unit for observation period of 24 hours, after 
which he/she was shifted to post operative ward.  
                              Adequate pain relief, appropriate antibiotic cover and 
daily ICD tube care, sterile precautions for dressing were provided to 
ensure safe and uneventful post operative stay. Check x rays were taken on 
immediate postoperative period, day 2 and day 7 for follow up. 
 
DIAGNOSIS AND FOLLOW UP  : 
                              Once the final diagnosis from the histopathological 
report of the thoracoscopic biopsy arrives the patients were informed 
immediately. Based on the diagnosis, the patients were managed 
accordingly with antitubercular treatment or prompt oncology referral for 
chemotherapy or radiotherapy or other modalities.  
ETHICAL CONSIDERATIONS: 
• Since medical thoracoscopy is an invasive procedure, all patients 
subjected to the procedure were done so only after getting a fully 
informed consent, explaining about the importance of the procedure 
to make a diagnosis & for treatment. 
• Another consent form in local language providing information 
regarding the procedure and willingness to take part in studies was 
also obtained.  
• The required approval letters from Institutional Ethical Committee of 
Stanley medical college & Institutional Review Board of 
Government hospital of thoracic medicine was obtained 
 
 
 
 
 
 
 
 
 
RESULTS 
                                  The results of  the value of thoracoscopic biopsy 
performed in 82 cases of hemorrhagic pleural effusions who satisfied 
the inclusion and exclusion criteria, done at a tertiary care hospital in 
Tamilnadu , South India  are shown below 
 
1.AGE DISTRIBUTION: 
                                       The maximum number of patients were in the age 
group of fifty one to sixty years [n=29]. The patient with the lowest age 
was thirty one years and maximum age was seventy six years. Five patients 
were above seventy years and tolerated the procedure well. 
 
Age Distribution: 
AGE IN YEARS NO. OF PATIENTS PERCENTAGE 
31 TO 40 15 18.29% 
41 TO 50 22 26.82% 
51 TO 60 29 35.36% 
61 TO 70 11 13.41% 
>70 5 0.06% 
                                     The younger age group had tuberculous etiology 
more common than malignancy. The statistical analysis revealed that age 
did not have a significant association with the final diagnosis  [p value > 
0.05 ]. 
 
2.  SEX DISTRIBUTION 
                                   Among the 82 patients 57 were male and 25 were 
female. There was no selection bias as all patients who met the inclusion 
criteria were included in the study. On analysis it was discovered that the 
sex of the patient did not have significant correlation with the diagnosis. 
Sex Distribution: 
SEX NO. OF PATIENTS PERCENTAGE 
MALE 57 69.51% 
FEMALE 25 30.48% 
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3.PLEURAL FLUID CELL TYPE: 
           
                          The predominant pleural fluid cell type was lymphocytes 
in seventy nine of the eighty two patients. Three remaining patients had in 
addition to lymphocytes plenty of mesothelial cells. One among these had 
mesothelial count > 10% .All these three patients turned out to be 
mesotheliomas. The other cells found in plenty were erythrocytes.   
 
Pleural fluid cell type: 
PLEURAL 
FLUIDCELL TYPE 
NO. OF PATIENTS PERCENTAGE 
LYMPHOCYTES 79 96.34% 
LYMPHOCYTES + 
MESOTHELIAL 
CELLS 
3 3.6% 
 
4. PLEURAL FLUID GLUCOSE: 
 
                                 A total of fifty nine patients had pleural fluid sugar 
values in between 40 to 60 mg/dl. Three patients had sugar values of less 
than 20 mg/dl and showed extensive involvement of the pleural surfaces.        
                                The mean pleural fluid glucose value was 46 mg/dl.  
The pleural fluid glucose values had a significant association with the 
diagnosis and the p value was found to be significant. 
 
Pleural fluid glucose: 
PLEURAL FLUID 
GLUCOSE mg/dl 
NO. OF PATIENTS PERCENTAGE 
<20 3 3.6% 
21 to 40 14 17.07% 
41 to 60 59 71.95% 
>60 6 7.31% 
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5. PLEURAL FLUID PROTEIN: 
 
                          Sixty two patients had pleural fluid protein values above 
4.0 mg/dl. All the eighty two patients were classified as exudates as per 
light`s criteria. Hence the protein values did not have any significant 
association with the final diagnosis. 
 
Pleural fluid protein: 
PROTEIN mg/dl NO. OF PATIENTS PERCENTAGE 
3.1 to 4 20 37.03% 
4.1 to 5 54 65.85% 
>5 8 9.75% 
 
 
 
 
 
 
6. PLEURAL FLUID pH: 
                          The lowest pleural fluid pH recorded was7.10. Fifteen 
patients had ph below 7.20. The maximum number of patients had the ph in 
range of 7.21 to 7.30.   
                          The pH of pleural fluid did not have any significant 
association with the final diagnosis[ p value was not significant].The mean 
pH was 7.28.  
Pleural fluid Ph: 
Ph NO. OF PATIENTS PERCENTAGE 
7.1 to 7.2 15 18.29% 
7.21 to 7.3 32 39.02% 
7.31 to 7.4 26 31.70% 
7.4 to 7.5 9 10.97% 
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 7. PLEURAL CYTOLOGY FOR MALIGNANT CELLS: 
                                   
                             The pleural fluid cytology for malignant cells was 
positive in twenty three out of the total eighty two patients [28% of the 
patients]  
 
Pleural cytology for malignant cells: 
PLEURAL 
CYTOLOGY FOR  
MALIGNANT 
CELLS 
NO. OF PATIENTS PERCENTAGE 
Positive 23 28% 
Negative 59 72% 
 
 
 
 
 
 
 8. CHEST X RAY FINDINGS: 
 
                             The most common chest x ray finding was massive 
effusion [n=40] followed by moderate effusion [n=39]. Three patients had 
bronchopneumonia like findings with moderate effusion. These three 
turned out to be bronchioloalveolar cell carcinoma. The chest X rays were 
assessed by one radiologist to avoid inter observer bias. 
Chest x ray findings: 
FINDINGS NO .OF PATIENTS PERCENTAGE 
Bronchopneumonia 
with effusion 
3 3.65% 
Moderate effusion 40 48.78% 
Massive effusion 39 47.56% 
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9. CONTRAST ENHANCED CT SCAN CHEST FINDINGS: 
   Contrast enhanced CT scan chest findings: 
FINDING 
NO.OF 
PATIENTS 
PERCENTAGE
Irregular nodularity+thickening+pleural 
plaques 
3 3.65% 
Effusion+pleural thickening pleural 
irregularity 
3 3.65% 
Effusion+pleural thickening (?BAC) 3 3.65% 
Effusion +pleural thickening 20 24.39% 
Effusion+pleural nodularity+pleural 
thickening+parenchymal nodule 
6 7.31% 
Effusion+pleural nodularity+pleural 
thickening 
6 7.31% 
Effusion+pleural nodularity 41 50% 
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                               The most common finding on chest ct scan was pleural 
nodularity[n=41]. The second most common finding was pleural 
thickening[n=20]. Pleural plaques were found in three patients who 
eventually turned out to be mesothelioma.  
 
                                 The CT scans were evaluated by one competent 
radiologist to avoid inter observer bias. Contrast ct scans were only an aid 
to a diagnosis and guide to further interventions. They were also useful to 
localize parenchymal lesions if any were present. Such parenchymal 
lesions if found were subjected to image guided biopsy to rule out the 
possibility of  lung primary. 
 
 
 
 
 
 
 
 
10. THORACOSCOPIC BIOPSY RESULTS : 
Thoracoscopic biopsy: 
BIOPSY 
NO. OF 
PATIENTS 
PERCENTAGE
Infiltrating adenocarcinoma 15 18.29% 
Bronchioloalveolar carcinoma 6 7.31% 
Lymphoma 3 3.65% 
Mesothelioma 3 3.65% 
Mucinous adenocarcinoma 5 6.09% 
Mixed type adenocarcinoma 7 8.53% 
Papillary adenocarcinoma 8 9.75% 
Secondary carcinomatous 
deposits 
12 14.63% 
Squamous cell carcinoma 
variant 
3 3.65% 
Tb granuloma 11 13.41% 
Unknown 9 10.97% 
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      Among the eighty two patients thoracoscopic pleural biopsy yielded a 
diagnosis in seventy three patients [89 %]. The diagnosis was malignancy 
in sixty two patients [75%] and tuberculosis in eleven  patients [13%].  
                           In the remaining nine patients a diagnosis could not be 
arrived at even after biopsy. Reasons for this could be inadequate biopsy 
specimen, inappropriate selection of biopsy sites due to inter observer 
variations etc 
 
 
 
 
 
 
 
 
 
 
11. INTERPRETATION OF THORACOSCOPIC BIOPSY 
RESULTS: 
                                 Among the patients diagnosed as malignancy [n-62], 
the most common histological type was infiltrating adenocarcinoma[n= 15] 
followed by secondary carcinomatous deposits[n=12]. The third most 
common diagnosis was tuberculosis [n=11]. Three rare diagnoses of 
lymphoma, mesothelioma and squamous cell carcinoma variant were seen. 
                                The consolidated results of the three groups are 
summarized in table-1 below. 
 Interpretation of thoracoscopic biopsy results: 
BIOPSY RESULT NO. OF PATIENTS PERCENTAGE 
MALIGNANCY 62 76% 
TUBERCULOSIS 11 13% 
UNKNOWN 9 11% 
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Comparison of imaging modalities: 
FACTORS MALIGNANCY TUBERCULOSIS UNKNOWN 
Chest x ray 
Massive 
effusion[33/62], 
moderate 
effusion [29/62] 
 
 
Moderate effusion 
[11/11] 
 
 
Massive [2/9], 
moderate [7/9] 
CT scan with 
Contrast 
Pleural nodularity 
/irregularity with 
effusion[48/62], 
parenchymal 
nodule [14/62] 
Pleural thickening 
with 
effusion[11/11] 
Pleural 
thickening / 
irregularity with 
effusion[9/9] 
 
 
 
 
 
PLEURAL FLUID AND PATIENT CHARACTERISTICS: 
 
FACTORS 
MALIGNANCY 
 
TUBERCULOSIS 
 
UNKNOWN
 
Clinical 
picture[most 
common 
symptoms] 
Chest 
discomfort, 
dyspnea 
Chest discomfort, 
dyspnea 
Chest 
discomfort, 
dyspnea 
Pleural fluid [based 
on protein] 
Exudate Exudate Exudate 
Pleural fluid AFB Negative Negative Negative 
Pleural fluid 
Cytology[malignant 
cells] 
Positive[23/62] 
Negative 
[11/11] 
Negative 
[9\9] 
Pleural fluid sugar [Mean] 43 [mean]46 [mean]51 
Pleural fluid ph [mean]7.28 [mean]7.4 [mean]7.35 
 
COMPARISION OF FOB AND THORACOSCOPY: 
 
FACTORS MALIGNANCY  TUBERCULOSIS UNKNOWN  
bronchoscopy 
Bronchial wash 
positive for 
malignancy 
[15/62] 
Negative[9/11] , 
wash 
positive[2/11] 
Brush ,wash 
negative [9/9] 
Thoracoscopic 
biopsy 
Positive 
[62/62] 
Positive[11/11] 
Inconclusive 
[9/9] 
 
 
 
 
 
 
STATISTICAL ANALYSIS: 
                          The patient characteristics were collected and 
recorded.they were analysed using descriptive statistics namely 
     -mean 
     -median 
      -range 
The influence of the various study factors on the final diagnosis was 
studied using the following tests 
-Pearson’s Chi Square 
-Fischers Exact Test 
-Chi Square with Yate’s Correction 
 
Statistical vaiue of the study is tabulated as follows: 
 
 
 
 
INFLUENCE OF THE STUDY PARAMETERS ON THE 
DIAGNOSIS: 
 
 
 
 
   
PARAMETER 
MEAN 
VALUE 
CHI SQUARE 
VALUE 
P VALUE 
PLEURAL 
FLUID 
GLUCOSE 
46 mg/dl 4.03 0.0447 
PLEURAL 
FLUID 
PROTEIN 
4.5mg/dl 0.34 0.5608 
SEX - 0.01 0.9504 
AGE 51 years 2.76 0.0966 
PLEURAL 
FLUID PH 
7.28 0.34 0.5611 
  
  
 
 
 
  
                                       DISCUSSION 
                                      In this study the primary aim was to study the 
results of thoracoscopic biopsy in cases of hemorrhagic pleural effusions. 
Through this study it was also attempted to list out criteria for hemorrhagic 
effusions . 
 
                                     Hemorrhagic effusions were defined based on the 
pleural fluid RBC count, hematocrit and the nature of fluid seen during the 
tapping procedure. The effusion was confirmed earlier by chest x ray and 
ultrasound. The total number of patients that met the criteria during the 
study period of 24 months from May 2011 to April 2012 was eighty two. 
Among them 57 were male patients and 25 were female patients.   
 
                                     All the selected patients underwent routine 
investigations. After ascertaining that they had adequate maneuvering 
space between the pleurae by ultrasound, they were subjected to 
thoracoscopy. During thoracoscopy the parietal, visceral and diaphragmatic 
pleurae were visualized.  
                                     Any abnormal areas were biopsied under direct 
surveillance . a minimum of three and maximum of six biopsies were done 
per patient. After the procedure the ICD tube of appropriate size was left in 
situ. All the 82 patients consented for the procedure as they were 
adequately counseled and well informed regarding the safety and the 
necessity of the procedure. The results were analysed using the following 
statistical parameters-Chi square test with Yates correction,Fischer`s exact t 
test. 
 
                                    In this study the age of the patients varied between 
31 to 76 years. When analyzing the association of age and the final 
diagnosis [both malignancy and tuberculosis], there was no significance 
with regard to the p value [p>0.05]. Hence it was inferred that age was not 
a significant predictor of the disease in our group of hemorrhagic effusion 
patients.                 
 
                                     In the sex distribution ,since the male and female 
patients were not equal in number, the sexual predilection for a particular 
diagnosis could not be assessed. 
                                    When looking at the pleural fluid cytology all 82 
cases were lymphocytic effusions. Among them 3 cases had high pleural 
fluid mesothelial cell count.All the 9 cases in which the diagnosis was still 
elusive were also lymphocytic effusions. The three cases with mesothelial 
cells rich pleural fluid turned out to be mesotheliomas . 
                                 
                                    It is an accepted thought that pleural fluid glucose is 
low in cases of malignancy. Three patients with pleural fluid glucose value 
less than 20mg/dl turned out to be infiltrating adenocarcinomas. Among the 
patients in the tuberculosis group the mean sugar value was 46 mg/dl. 
                                    
                                    On assessing whether the pleural fluid sugar value 
had any significance with relation to the final diagnosis it was found that 
the p value was significant[p value=0.0447]. Among the group of patients 
whose diagnosis was unknown the mean sugar value was 51 mg/dl. Of the 
82 patients 14 patients were diabetic patients who were under insulin for 
glycemic control during the hospital stay. 
                                      All 82 cases were exudative effusions as classified 
by light`s criteria. The mean protein value was 4.5 mg/dl. [p 
value=0..5608].The pleural fluid protein levels had no significance of 
correlation with the diagnosis . 
                               Malignancy is one of the causes of a low pleural fluid 
pH. In this study the average value was 7.28. There was no significant 
correlation between pH and the final diagnosis and the p value was not 
significant [ p value=0.5611]. The least value recorded was 7.1 which was 
recorded in the case of an infiltrating adenocarcinoma. 
                              
                              Pleural fluid cytology for malignant cells was positive in 
23 of the 82 patients i.e in 28 % of patients. This gives a sensitivity of 
37.10%[95% confidence interval 25.17% to 50.31%]. The calculated 
negative predictive value is 33.90%[95% confidence interval 22.09% to 
47.39%]. Among the 23 patients,15 patients had adenocarcinoma. Of the 
other 8 patients 5 had secondary deposits of the pleura.     
                                
                                  The radiological investigations namely the chest x ray 
and the contrast enhanced computed tomography scan were not definitive 
diagnostic modalities. They were aids to the diagnosis and acted as guide to 
the thoracoscopy procedure. 
                                
                                        Of the 82 patients in the study 2 patients 
developed empyema and were treated with appropriate antibiotics .There 
was 8 deaths reported in the study group during the study period. Seven of 
these deaths were in the malignancy group most likely due to the disease 
per se and occurred after referral  to oncology department for 
chemotherapy or radiotherapy.  
 
                                  One death was reported in the unknown group 3 
months after being discharged at request from our institution and cause 
could not be discovered. There were no deaths attributed to the procedure 
of thoracoscopy further strengthening the idea that it is a very safe 
procedure.                          
 
                                  The yield of our study was 89.02% i.e. we were able 
to arrive at a diagnosis in 73 patients out of 82. The following observations 
were also made at the end of the study: 
 
• All the 73 patients had a short hospital stay. The mean duration of 
hospital stay was 8 days. 
 
• The thoracoscopy was done as a third step in the diagnostic 
algorithm.  
 
• After routine blood investigations, first step was diagnostic tapping. 
Next was radiological assessment namely chest x ray, ultrasound 
chest & CECT chest and date fixation for thoracoscopy.  
 
• After full pulmonary assessment the patient was taken up for 
thoracoscopy. 
 
•  Because of such an algorithm the patients had 3 important benefits- 
early relief of symptoms, early confirmation of diagnosis and early 
referral to oncology or antitubercular therapy. 
 
• Patient satisfaction in terms of physical and psychological aspects 
was very good.   
 
• The positive predictive value of the procedure for malignancy in this 
study was 84.9% .  
 
• The second most common cause of hemorrhagic effusions in our 
study was tuberculosis [11 out of 82 patients i.e 13%  of the cases]. 
This turned out to be very important finding both for us and the 
patients.  
 
• Six of these 11 patients had been referred to our institution as 
suspected malignant effusions by private hospitals and practitioners. 
When they came to know of the diagnosis and were promptly started 
on antitubercular therapy, the patients were happy and relieved to 
know that they did not have malignancy.    
 
• The follow up of all the patients in the study group was done during 
the study period. The outcome of 54 patients were obtained and 
analysed. The remaining 28 patients could not be traced because of 
various reasons.  
 
• Eight patients in the malignancy group had expired. All patients in 
the tuberculosis group had survived and completed antitubercular 
treatment. 
 
• Among the patients in the group where even after thoracoscopy a 
diagnosis was not established [total 9 patients] none was willing for 
a repeat procedure or further investigations. All of them had opted 
for discharge at request since they were symptomatically better.  
 
 • The patients in the malignancy group who were referred to oncology 
department were registered for chemotherapy and were on follow up. 
They were also registered in the palliative clinic. 
• In patients with secondaries of the pleura the primary could not be 
identified in 50% of the cases.  
Among twelve cases of pleural secondaries the primary tumor site was 
identified in six persons. 2 had primary in bone[tibia] ,one had history of  
surgery in gastrointestinal tract for suspected malignancy ,two females with 
prior breast carcinoma, one other patient with lymphoma 
 
 
 
 
 
 
 
 
 
 CONCLUSION 
 
 
                        In cases that are classified as hemorrhagic effusions, early 
intervention in the form of medical thoracoscopy is valuable in both 
diagnostic and therapeutic aspects. The advantages include early relief of 
symptoms, early diagnosis and early initiation of appropriate therapy. The 
total hospital stay is comparatively less and the overall patient satisfaction 
is good. Malignancy and tuberculosis were the two leading causes of 
hemorrhagic effusions in this study. The complication rate was negligible. 
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 Annexure-1                  PROFORMA 
Name :    Age:                    Gender: 
Occupation    : 
Address    : 
Phone No                                   : 
Height/Weight                           : 
Smoking      :  Yes / No 
Brand/quantity/Duration 
If stopped when? 
Alcohol use             :  Yes / No 
Brand/quantity/Duration 
If  stopped when? 
Tobacco use                      : Chew/Snuff   No of times/day 
 
COMORBID CONDITIONS: 
Pregnancy   : Yes/No 
Peptic ulcer   : Yes/No 
Bronchial Asthma  : Yes/No 
Hypertension   : Yes/No 
Diabetes mellitus  : Yes/No 
SYMPTOMS 
Cough : 
Fever : 
Sputum : 
Chestpain : 
Haemoptysis : 
Wheeze : 
Contact history of Tuberculosis : yes/no 
 
PREVIOUS H/O ANTI TB MEDICATION[DETAILS]; 
 
EXAMINATION 
GENERAL     :             Anaemia 
Lymphadenopathy 
Jaundice 
Spine 
Pedal edema 
VITALS : 
PR:                          BP: 
RR:              Temp: 
 
RESPIRATORY SYSTEM : 
Inspection : 
Palpation : 
Percussion : 
Auscultation : 
PER ABDOMEN : 
CARDIOVASCULAR SYSTEM : 
CENTRAL NERVOUS SYSTEM : 
INVESTIGATIONS : 
RBS                           : 
UREA, CREATININE : 
RBC COUNT                    : 
PCV                                   : 
BT / CT                              : 
PLEURAL FLUID ASPIRATION NOTES : 
PLEURAL FLUID :         SUGAR 
PROTEIN 
CELL COUNT 
LDH 
RBC COUNT 
PCV 
CYTOLOGY FOR [MALIGNANT CELLS] 
MANTOUX : 
SPUTUM for AFB : 
CHEST X RAY: 
CT- CHEST: 
THORACOSOPIC FINDINGS 
THORACOSCOPIC BIOPSY RESULTS- 
OTHER INVESTIGATIONS: 
FINAL DIAGNOSIS : 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Annexure-2                    CONSENT FORM  
 
 
 
Annexure-3-             Consent form in tamil 
 
  
 
  
 
Annexure-4              Ethical committee approval letter 
 
 
 
 
Annexure – 5              IRB approval letter 
 
 
 
Annexure-6          Letter of safety submitted to ethical committee 
 
    
  
